# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-25-115489
Filing Date
2025-05-08
Accepted
2025-05-08 07:36:06
Documents
59
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d892783d8k.htm iXBRL | 8-K | 26418
2 | EX-99.1 | d892783dex991.htm | EX-99.1 | 100919
3 | EX-99.2 | d892783dex992.htm | EX-99.2 | 45043
7 | GRAPHIC | g892783dsp050.jpg | GRAPHIC | 5527
8 | GRAPHIC | g892783ex99_2p10g1.jpg | GRAPHIC | 206166
9 | GRAPHIC | g892783ex99_2p11g1.jpg | GRAPHIC | 229430
10 | GRAPHIC | g892783ex99_2p12g1.jpg | GRAPHIC | 266385
11 | GRAPHIC | g892783ex99_2p13g1.jpg | GRAPHIC | 268966
12 | GRAPHIC | g892783ex99_2p14g1.jpg | GRAPHIC | 213619
13 | GRAPHIC | g892783ex99_2p15g1.jpg | GRAPHIC | 163663
14 | GRAPHIC | g892783ex99_2p16g1.jpg | GRAPHIC | 257484
15 | GRAPHIC | g892783ex99_2p17g1.jpg | GRAPHIC | 234484
16 | GRAPHIC | g892783ex99_2p18g1.jpg | GRAPHIC | 180476
17 | GRAPHIC | g892783ex99_2p19g1.jpg | GRAPHIC | 256652
18 | GRAPHIC | g892783ex99_2p1g1.jpg | GRAPHIC | 297533
19 | GRAPHIC | g892783ex99_2p20g1.jpg | GRAPHIC | 267818
20 | GRAPHIC | g892783ex99_2p21g1.jpg | GRAPHIC | 139952
21 | GRAPHIC | g892783ex99_2p22g1.jpg | GRAPHIC | 292036
22 | GRAPHIC | g892783ex99_2p23g1.jpg | GRAPHIC | 286949
23 | GRAPHIC | g892783ex99_2p24g1.jpg | GRAPHIC | 203866
24 | GRAPHIC | g892783ex99_2p25g1.jpg | GRAPHIC | 198127
25 | GRAPHIC | g892783ex99_2p26g1.jpg | GRAPHIC | 322412
26 | GRAPHIC | g892783ex99_2p27g1.jpg | GRAPHIC | 178355
27 | GRAPHIC | g892783ex99_2p28g1.jpg | GRAPHIC | 277365
28 | GRAPHIC | g892783ex99_2p29g1.jpg | GRAPHIC | 253583
29 | GRAPHIC | g892783ex99_2p2g1.jpg | GRAPHIC | 371532
30 | GRAPHIC | g892783ex99_2p30g1.jpg | GRAPHIC | 289454
31 | GRAPHIC | g892783ex99_2p31g1.jpg | GRAPHIC | 190830
32 | GRAPHIC | g892783ex99_2p32g1.jpg | GRAPHIC | 249610
33 | GRAPHIC | g892783ex99_2p33g1.jpg | GRAPHIC | 237348
34 | GRAPHIC | g892783ex99_2p34g1.jpg | GRAPHIC | 145728
35 | GRAPHIC | g892783ex99_2p35g1.jpg | GRAPHIC | 323195
36 | GRAPHIC | g892783ex99_2p36g1.jpg | GRAPHIC | 293440
37 | GRAPHIC | g892783ex99_2p37g1.jpg | GRAPHIC | 249394
38 | GRAPHIC | g892783ex99_2p38g1.jpg | GRAPHIC | 207189
39 | GRAPHIC | g892783ex99_2p39g1.jpg | GRAPHIC | 241224
40 | GRAPHIC | g892783ex99_2p3g1.jpg | GRAPHIC | 256720
41 | GRAPHIC | g892783ex99_2p40g1.jpg | GRAPHIC | 149382
42 | GRAPHIC | g892783ex99_2p41g1.jpg | GRAPHIC | 255971
43 | GRAPHIC | g892783ex99_2p42g1.jpg | GRAPHIC | 215114
44 | GRAPHIC | g892783ex99_2p43g1.jpg | GRAPHIC | 179673
45 | GRAPHIC | g892783ex99_2p4g1.jpg | GRAPHIC | 300198
46 | GRAPHIC | g892783ex99_2p5g1.jpg | GRAPHIC | 226341
47 | GRAPHIC | g892783ex99_2p6g1.jpg | GRAPHIC | 218926
48 | GRAPHIC | g892783ex99_2p7g1.jpg | GRAPHIC | 139806
49 | GRAPHIC | g892783ex99_2p8g1.jpg | GRAPHIC | 248414
50 | GRAPHIC | g892783ex99_2p9g1.jpg | GRAPHIC | 250791
| Complete submission text file | 0001193125-25-115489.txt |  | 14439076

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | wve-20250508.xsd | EX-101.SCH | 2873
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | wve-20250508_lab.xml | EX-101.LAB | 17925
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | wve-20250508_pre.xml | EX-101.PRE | 11253
61 | EXTRACTED XBRL INSTANCE DOCUMENT | d892783d8k_htm.xml | XML | 3612

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 25923921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)